NCT00103012View on ClinicalTrials.gov

Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2011

Study Completion Date

June 30, 2011

Conditions

Healthy

Interventions

DRUG

Gingko Biloba

Ginkgo Biloba 120 mg twice daily for 14 days

DRUG

Echinacea purpurea

Echinacea purpurea 500 mg three times daily for 14 days

DRUG

Panax ginseng

Panax ginseng 500 mg twice daily

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00103012 - Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers | Biotech Hunter | Biotech Hunter